Clinical Trials · NCT01723774
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Washington University School of Medicine
- Enrollment
- 84
- Start date
- Apr 2013
- Locations
- 4 sites, United States
- Primary endpoint
- Number of Participants With Complete Cell Cycle Arrest at Cycle 1 Day 15 (PIK3CA Wild Type Cohort Only)